Home » Topics » BioWorld Science

BioWorld Science
RSS

Innovent licenses rights to GenFleet's KRAS G12C inhibitor GFH-925

Sep. 2, 2021

Discovery of novel potent and reversible MAGL inhibitors

Sep. 2, 2021

New compounds reduce intracellular c-di-GMP content in Pseudomonas aeruginosa

Sep. 2, 2021

Discovery of novel GluN2B PAMs as potential therapeutics for Alzheimer's disease

Sep. 2, 2021

New loci discovered for genetic disorders

Sep. 2, 2021

Data unveil NLGN3 as a candidate gene for GnRH deficiency

Sep. 2, 2021

IPO8 gene variants identified in Loyes-Dietz-like syndrome

Sep. 2, 2021

TCMCB-07 attenuates muscle wasting and body weight loss in murine models of cancer cachexia

Sep. 2, 2021

Researchers identify MTSS1 as a novel candidate gene for inherited retinal dystrophy

Sep. 2, 2021

New melanocortin receptor modulators presented by Palatin Technologies

Sep. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.